The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders
Bifeng Gao, An Doan, Brooks M HybertsonDepartment of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USAAbstract: Nuclear factor (erythroid-derived 2)-like 2 (Nrf2; encoded in humans by the NFE2L2 gene) is a transcript...
Guardado en:
Autores principales: | Gao B, Doan A, Hybertson BM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf9f044c9b0f430bbcd64b30122118c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
por: Hashemi SN, et al.
Publicado: (2012) -
Advances in the use of topical imiquimod to treat dermatologic disorders
por: Francesco Lacarrubba, et al.
Publicado: (2008) -
Retraction Notice to: circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway
por: Guojun Wu, et al.
Publicado: (2021) -
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
por: Lennox Chitsike, et al.
Publicado: (2021) -
Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes
por: Noo Ree Cho, et al.
Publicado: (2021)